In addition, nuclear localization of B7-H3 (23) and aberrant expression of B7-H3 in CD133+ CRC cells (26) were found to be closely associated with tumor progression and strongly predicted poor outcomes in CRC. This evidence concerns the gene CD276 and colorectal carcinoma.